TY - JOUR
T1 - Effect of statin treatment on three-month outcomes in patients with stroke-associated infection
T2 - A prospective cohort study
AU - Yeh, P. S.
AU - Lin, H. J.
AU - Chen, P. S.
AU - Lin, S. H.
AU - Wang, W. M.
AU - Yang, C. M.
AU - Li, Y. H.
PY - 2012/5
Y1 - 2012/5
N2 - Background and purpose: Infection is a major medical problem in patients with acute stroke. Recent evidences suggest that statins reduce infection-associated complications. The purpose of this study was to examine the influence of statin treatment on mortality and functional outcomes in patients with stroke-associated infection. Methods: In this prospective observational cohort study, 514 patients with acute ischaemic stroke or transient ischaemic attack (mean age, 74±11years; men, 48%) with infection occurring in the first 7days after admission were included. We examined the effect of in-hospital statin treatment on mortality and favorable functional outcome (modified Rankin Scale score ≤2) at 3months follow-up. Results: Infection occurred at 0.93±1.49days after admission. All patients had not received statin treatment prior to admission, and 121 patients (24%) received statin at 1.71±1.28days after admission. Follow-up at 3months was completed for 511 patients (99%). National Institutes of Health Stroke Scale score and Charlson index were the most important independent predictors of mortality and functional outcome. Univariate [hazard ratio (HR), 0.82; 95% confidence intervals (CI), 0.47-1.42] and multivariate (HR, 1.68; 95% CI, 0.79-3.56) Cox regression analysis showed that statin did not significantly decrease the morality. In propensity analysis, statin treatment still had no significant association with mortality (HR, 1.54; 95% CI, 0.68-3.47) in the multivariate analyses after adjusting for age, sex, and propensity score. Conclusions: Statin use was not associated with a better functional outcome or survival in patients with stroke-associated infection.
AB - Background and purpose: Infection is a major medical problem in patients with acute stroke. Recent evidences suggest that statins reduce infection-associated complications. The purpose of this study was to examine the influence of statin treatment on mortality and functional outcomes in patients with stroke-associated infection. Methods: In this prospective observational cohort study, 514 patients with acute ischaemic stroke or transient ischaemic attack (mean age, 74±11years; men, 48%) with infection occurring in the first 7days after admission were included. We examined the effect of in-hospital statin treatment on mortality and favorable functional outcome (modified Rankin Scale score ≤2) at 3months follow-up. Results: Infection occurred at 0.93±1.49days after admission. All patients had not received statin treatment prior to admission, and 121 patients (24%) received statin at 1.71±1.28days after admission. Follow-up at 3months was completed for 511 patients (99%). National Institutes of Health Stroke Scale score and Charlson index were the most important independent predictors of mortality and functional outcome. Univariate [hazard ratio (HR), 0.82; 95% confidence intervals (CI), 0.47-1.42] and multivariate (HR, 1.68; 95% CI, 0.79-3.56) Cox regression analysis showed that statin did not significantly decrease the morality. In propensity analysis, statin treatment still had no significant association with mortality (HR, 1.54; 95% CI, 0.68-3.47) in the multivariate analyses after adjusting for age, sex, and propensity score. Conclusions: Statin use was not associated with a better functional outcome or survival in patients with stroke-associated infection.
UR - http://www.scopus.com/inward/record.url?scp=84859817929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859817929&partnerID=8YFLogxK
U2 - 10.1111/j.1468-1331.2011.03608.x
DO - 10.1111/j.1468-1331.2011.03608.x
M3 - Article
C2 - 22176026
AN - SCOPUS:84859817929
VL - 19
SP - 689
EP - 695
JO - European Journal of Neurology
JF - European Journal of Neurology
SN - 1351-5101
IS - 5
ER -